It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Purpose: The policy for the treatment of severe malaria in Nigeria was revised in June 2011 to parenteral artesunate followed by a full course of artemisinin-based combination therapy. This audit assesses how well health care providers in public and private facilities comply with the current national treatment guidelines.
Patients and methods: A clinical audit was conducted on the patient case records of children below 5 years of age who were managed for severe malaria in Cross River State, southeastern Nigeria. Multi-staged sampling was used to select the secondary health facilities for the exercise. The audit was conducted between January 2012 and March 2012.
Results: A total of 119 cases of severe malaria in children under 5 were assessed in three public and 12 private facilities. Light microscopy was more frequently used in confirming the diagnosis of malaria than rapid diagnostic tests. Malaria smear was more commonly done in private than public facilities (P = 0.02). A majority of patients (81%) received parenteral antimalaria drugs, with intramuscular artemether (60.4%) being the most commonly prescribed. Only 58% and 47% of cases received correct doses of parenteral drugs in public and private facilities, respectively. More public facilities prescribed oral artemisinin-based combination therapy after discontinuation of parenteral drugs (P = 0.02).
Conclusion: There is need to improve the case management of severe malaria in both public and private facilities in the state. Health workers should be regularly updated on the amended guidelines for the management of severe malaria. We recommend the provision of rapid diagnostic test kits to health facilities.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer